Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?

This article reviews the available evidence on the use of biosimilar G-CSF in this setting. Aggregate clinical evidence supports the assessment by the EMA of biosimilar and originator G-CSF as highly biologically similar, with respect to desired and undesired effects. PMID: 24965197 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24965197?dopt=Abstract

Source: Transfusion - June 26, 2014 Category: Hematology Authors: Bonig H, Becker PS, Schwebig A, Turner M Tags: Transfusion Source Type: research